-
Pazopanib, an orally available multi-kinase inhibitor of VEGFR, PDGFR, KIT, FGFR, as well as RAF, shows potent activity against a variety of solid tumors. Pazopanib是多重靶点抑制剂，对VEGFR1， VEGFR2，VEGFR3，PDGFR，FGFR，c-Kit 和 c-Fms的IC50分别为10 nM，30 nM，47 nM，84 nM，74 nM，140 nM和146 nM。
More
-
Ponatinib (AP24534)是一种新型有效的作用于Abl， PDGFRα， VEGFR2， FGFR1和Src的多靶点抑制剂， IC50分别为0.37 nM， 1.1 nM， 1.5 nM， 2.2 nM和5.4 nM。
More
-
Tranylcypromine hydrochloride is a racemic mixture of (±)-Trans-2-phenylcyclopropyl-1-amine (TCP, tPCPA) · HCl that covalently inhibits the LSD and MAO enzymes. Tranylcypromine (2-PCPA) HCl是一种非选择性的不可逆的单胺氧化酶(MAO)抑制剂，用作抗抑郁药和抗焦虑药。
More
-
Entinostat (MS-27-275, MS-275, SNDX-275) an orally class I histone deacetylase (HDAC)-specific inhibitor, is currently in clinical trials.
More
-
Tamoxifen citrate, a selective non-steroidal estrogen receptor antagonist, was approved by FDA as a drug that is utilized in the treatment of estrogen receptor–positive breast cancer. Tamoxifen Citrate是一种雌激素受体拮抗剂，与雌激素竞争性结合。
More
